Market Research Logo

Asuragen Inc - Product Pipeline Analysis, 2017 Update

Summary

Asuragen Inc (Asuragen) is a provider of laboratory medicine solutions. The company offers products which include amplidex, quantidex, and custom reagents. It offers custom and companion diagnostic services which include commercialization, product approval, development, discovery, partnered research and development and tumor bank programs. The company's custom reagents comprise armored reagents, in vitro transcribed RNA and plasmid DNA kits. It distributes its products in Algeria, Australia, Austria, Belgium, Brazil, Bulgaria, Denmark, Egypt, Germany, Iceland, India, the UAE, the UK and the US, among others. Asuragen is headquartered in Austin, Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Asuragen Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Asuragen Inc Company Overview
Asuragen Inc Company Snapshot
Asuragen Inc Pipeline Products and Ongoing Clinical Trials Overview
Asuragen Inc – Pipeline Analysis Overview
Asuragen Inc - Key Facts
Asuragen Inc - Major Products and Services
Asuragen Inc Pipeline Products by Development Stage
Asuragen Inc Pipeline Products Overview
Diagnostic Test - Neurodegenerative Disorders
Diagnostic Test - Neurodegenerative Disorders Product Overview
miRNA Based Sequencing Test - Esophageal Cancer
miRNA Based Sequencing Test - Esophageal Cancer Product Overview
miRNA Based Sequencing Test - Colon Cancer
miRNA Based Sequencing Test - Colon Cancer Product Overview
miRNA Based Sequencing Test - Lung Cancer
miRNA Based Sequencing Test - Lung Cancer Product Overview
miRNA Based Sequencing Test - Pancreatic Cancer
miRNA Based Sequencing Test - Pancreatic Cancer Product Overview
Signature CF Expand
Signature CF Expand Product Overview
Asuragen Inc - Key Competitors
Asuragen Inc - Key Employees
Asuragen Inc - Locations And Subsidiaries
Head Office
Recent Developments
Asuragen Inc, Recent Developments
Apr 25, 2017: Asuragen Strengthens Repetitive Sequence and Short Structural Variant Intellectual Property Portfolio
Mar 14, 2017: Asuragen Launches the AmplideX PCR/CE TOMM40 Kit Expanding Portfolio into the Alzheimer’s and Cognitive Impairment Space
Nov 01, 2016: Asuragen Launches QuantideX NGS RNA Lung Cancer Kit
Aug 09, 2016: Asuragen Develops Armored RNA Quant Zika Virus Control
Jul 25, 2016: Asuragen’s QuantideX qPCR BCR-ABL IS Kit Receives FDA Premarket Clearance For Monitoring Minimal Residual Disease In Chronic Myeloid Leukemia
Jul 06, 2016: Asuragen Launches the AmplideX PCR/CE C9orf72 Kit for High-Resolution Genotyping of GC-rich Repeat Expansions Relevant to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Apr 18, 2016: Asuragen to Present Expansion of Next-Generation Sequencing Portfolio at American Association for Cancer Research Annual Meeting
Nov 05, 2015: Asuragen Launches Amplidex PCR/CE FMR1 Reporter, A Fully Automated Software Solution For Accurate Sizing Of The FMR1 CGG Repeat Region
Jul 08, 2015: Asuragen Launches the Quantidex Pan Cancer Kit, a Workflow Solution for Targeted Next-Generation Sequencing
Jun 11, 2015: Asuragen Announces Launch of Highly Sensitive CE-IVD BCR-ABL Assay at the European Hematology Association Annual Congress
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tabless
Asuragen Inc Pipeline Products and Ongoing Clinical Trials Overview
Asuragen Inc Pipeline Products by Equipment Type
Asuragen Inc Pipeline Products by Indication
Asuragen Inc, Key Facts
Asuragen Inc, Major Products and Services
Asuragen Inc Number of Pipeline Products by Development Stage
Asuragen Inc Pipeline Products Summary by Development Stage
Diagnostic Test - Neurodegenerative Disorders - Product Status
Diagnostic Test - Neurodegenerative Disorders - Product Description
miRNA Based Sequencing Test - Esophageal Cancer - Product Status
miRNA Based Sequencing Test - Esophageal Cancer - Product Description
miRNA Based Sequencing Test - Colon Cancer - Product Status
miRNA Based Sequencing Test - Colon Cancer - Product Description
miRNA Based Sequencing Test - Lung Cancer - Product Status
miRNA Based Sequencing Test - Lung Cancer - Product Description
miRNA Based Sequencing Test - Pancreatic Cancer - Product Status
miRNA Based Sequencing Test - Pancreatic Cancer - Product Description
Signature CF Expand - Product Status
Signature CF Expand - Product Description
Asuragen Inc, Key Employees
Glossary
List of Figures
Asuragen Inc Pipeline Products by Equipment Type
Asuragen Inc Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report